IP Library Granted Patent US 9,339,564
Granted Patent B2
US 9,339,564 · App. 13/887,981 · Granted May 17, 2016

Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer

Inventors: Jamey P. Weichert (Fitchburg, WI); Anatoly Pinchuk (Madison, WI); Irawati Kandela (Madison, WI); Marc Longino (Verona, WI); William R. Clarke (Colgate, WI)
Assignee: CELLECTAR, INC.
A61K51/0408A61K45/06A61K51/0489
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,339,564
App. No.
13/887,981
Granted
May 17, 2016
Kind
B2
Abstract

Methods and compositions utilizing ether and alkyl phospholipid ether analog compounds for treating cancer and imaging, monitoring, and detecting cancer stem cells in humans.

Claims (6)

1. A method of treating cancer comprising administering to a patient in need thereof a therapeutically effective amount of 18-(p-iodophenyl)octadecyl phosphocholine) radiolabeled with 131 I or 125 I in combination with external beam radiation therapy, wherein the cancer comprises cancer stem cells and the number of cancer stem cells is reduced.

2. The method of claim 1 , wherein the cancer is selected from the group consisting of glioma, lung cancer, squamous cell carcinoma, renal cancer, melanoma, colorectal cancer, ovarian cancer, prostate cancer, breast cancer, and pancreatic cancer.

3. The method of claim 1 , wherein the isotope of iodine is 131 I.

4. The method of claim 1 , wherein the isotope of iodine is 125 I.

5. The method of claim 1 , wherein the method further comprises another cancer therapy selected from the group consisting of chemotherapy, tumor resection, abalative therapy, and local physical treatment on the basis of cold (cryo), heat (thermal), radiofrequency, and microwave.

6. The method of claim 1 , wherein the method of treatment enhances the radiosensitivity of the cancer.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2013
From: WEICHERT, JAMEY P.; PINCHUK, ANATOLY; KANDELA, IRAWATI; LONGINO, MARC; CLARKE, WILLIAM R.
To: CELLECTAR, INC.
Reel/Frame 030503/0778 →
MERGER Recorded May 29, 2013
From: CELLECTAR, INC.
To: CELL ACQUISITION CORP.
Reel/Frame 030503/0855 →
CHANGE OF NAME Recorded May 29, 2013
From: CELL ACQUISITION CORP.
To: CELLECTAR, INC.
Reel/Frame 030508/0344 →
Continuity (3)
Continuation 12813992 · Jun 11, 2010
Provisional Application 61186600 · Jun 12, 2009
Related Publication 20130343991A1 · Dec 26, 2013